AAAAAA

   
Results: 1-25 | 26-38 |
Results: 26-38/38
BONE-MARROW TRANSPLANTATION FOR THALASSEMIA - THE USA EXPERIENCE
Authors: WALTERS MC THOMAS ED
Citation: Mc. Walters et Ed. Thomas, BONE-MARROW TRANSPLANTATION FOR THALASSEMIA - THE USA EXPERIENCE, The American journal of pediatric hematology/oncology, 16(1), 1994, pp. 11-17
MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - A RANDOMIZED STUDY COMPARING CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION WITH BUSULFAN AND CYCLOPHOSPHAMIDE
Authors: CLIFT RA BUCKNER CD THOMAS ED BENSINGER WI BOWDEN R BRYANT E DEEG HJ DONEY KC FISHER LD HANSEN JA MARTIN P MCDONALD GB SANDERS JE SCHOCH G SINGER J STORB R SULLIVAN KM WITHERSPOON RP APPELBAUM FR
Citation: Ra. Clift et al., MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - A RANDOMIZED STUDY COMPARING CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION WITH BUSULFAN AND CYCLOPHOSPHAMIDE, Blood, 84(6), 1994, pp. 2036-2043
CYCLOPHOSPHAMIDE COMBINED WITH ANTITHYMOCYTE GLOBULIN IN PREPARATION FOR ALLOGENEIC MARROW TRANSPLANTS IN PATIENTS WITH APLASTIC-ANEMIA
Authors: STORB R ETZIONI R ANASETTI C APPELBAUM FR BUCKNER CD BENSINGER W BRYANT E CLIFT R DEEG HJ DONEY K FLOWERS M HANSEN J MARTIN P PEPE M SALE G SANDERS J SINGER J SULLIVAN KM THOMAS ED WITHERSPOON RP
Citation: R. Storb et al., CYCLOPHOSPHAMIDE COMBINED WITH ANTITHYMOCYTE GLOBULIN IN PREPARATION FOR ALLOGENEIC MARROW TRANSPLANTS IN PATIENTS WITH APLASTIC-ANEMIA, Blood, 84(3), 1994, pp. 941-949
MARROW TRANSPLANTATION FOR PATIENTS IN ACCELERATED PHASE OF CHRONIC MYELOID-LEUKEMIA
Authors: CLIFT RA BUCKNER CD THOMAS ED BRYANT E ANASETTI C BENSINGER WI BOWDEN R DEEG HJ DONEY KC FISHER LD HANSEN JA MARTIN P MCDONALD GB SANDERS JE SCHOCH G SINGER J STORB R SULLIVAN KM WITHERSPOON RP APPELBAUM FR
Citation: Ra. Clift et al., MARROW TRANSPLANTATION FOR PATIENTS IN ACCELERATED PHASE OF CHRONIC MYELOID-LEUKEMIA, Blood, 84(12), 1994, pp. 4368-4373
SYNGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE - UPDATE OF THE ORIGINAL 14 SEATTLE PATIENTS - INCLUDING PCR RESULTS
Authors: FEFER A RADICH J PAVLETIC Z CHEEVER MA GREENBERG PD APPELBAUM FR CLIFT RA STORB R SANDERS J SULLIVAN K BUCKNER CD THOMAS ED
Citation: A. Fefer et al., SYNGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE - UPDATE OF THE ORIGINAL 14 SEATTLE PATIENTS - INCLUDING PCR RESULTS, Blood, 84(10), 1994, pp. 10000252-10000252
LONG-TERM FOLLOW-UP OF A RANDOMIZED TRIAL OF GRAFT-VERSUS-HOST DISEASE PREVENTION BY METHOTREXATE CYCLOSPORINE VERSUS METHOTREXATE ALONE INPATIENTS GIVEN MARROW GRAFTS FOR SEVERE APLASTIC-ANEMIA/
Authors: STORB R LEISENRING W DEEG HJ ANASETTI C APPELBAUM F BENSINGER W BUCKNER CD CLIFT R DONEY K HANSEN J MARTIN P SANDERS J STEWART P SULLIVAN K THOMAS ED WITHERSPOON R
Citation: R. Storb et al., LONG-TERM FOLLOW-UP OF A RANDOMIZED TRIAL OF GRAFT-VERSUS-HOST DISEASE PREVENTION BY METHOTREXATE CYCLOSPORINE VERSUS METHOTREXATE ALONE INPATIENTS GIVEN MARROW GRAFTS FOR SEVERE APLASTIC-ANEMIA/, Blood, 83(9), 1994, pp. 2749-2750
BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA - REPLY
Authors: CLIFT RA APPELBAUM FR THOMAS ED
Citation: Ra. Clift et al., BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA - REPLY, Blood, 83(9), 1994, pp. 2752-2753
AUTOLOGOUS MARROW TRANSPLANTATION FOR PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN UNTREATED 1ST RELAPSE OR IN 2ND COMPLETE REMISSION
Authors: PETERSEN FB LYNCH MHE CLIFT RA APPELBAUM FR SANDERS JE BENSINGER WI BENYUNES MC DONEY K FEFER A MARTIN P STORB R ROWLEY S SULLIVAN KM WITHERSPOON R WEIDEN P THOMAS ED FISHER L HANSEN JA BUCKNER CD
Citation: Fb. Petersen et al., AUTOLOGOUS MARROW TRANSPLANTATION FOR PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN UNTREATED 1ST RELAPSE OR IN 2ND COMPLETE REMISSION, Journal of clinical oncology, 11(7), 1993, pp. 1353-1360
ALLOGENEIC, SYNGENEIC, AND AUTOLOGOUS MARROW TRANSPLANTATION FOR HODGKINS-DISEASE - THE 21-YEAR SEATTLE EXPERIENCE
Authors: ANDERSON JE LITZOW MR APPELBAUM FR SCHOCH G FISHER LD BUCKNER CD PETERSEN FB CRAWFORD SW PRESS OW SANDERS JE BENSINGER WI MARTIN PJ STORB R SULLIVAN KM HANSEN JA THOMAS ED
Citation: Je. Anderson et al., ALLOGENEIC, SYNGENEIC, AND AUTOLOGOUS MARROW TRANSPLANTATION FOR HODGKINS-DISEASE - THE 21-YEAR SEATTLE EXPERIENCE, Journal of clinical oncology, 11(12), 1993, pp. 2342-2350
TREATMENT OF CHRONIC MYELOID-LEUKEMIA BY MARROW TRANSPLANTATION
Authors: CLIFT RA APPELBAUM FR THOMAS ED
Citation: Ra. Clift et al., TREATMENT OF CHRONIC MYELOID-LEUKEMIA BY MARROW TRANSPLANTATION, Blood, 82(7), 1993, pp. 1954-1956
A RANDOMIZED CONTROLLED TRIAL OF PENTOXIFYLLINE FOR THE PREVENTION OFREGIMEN-RELATED TOXICITIES IN PATIENTS UNDERGOING ALLOGENEIC MARROW TRANSPLANTATION
Authors: CLIFT RA BIANCO JA APPELBAUM FR BUCKNER CD SINGER JW BAKKE L BENSINGER WI BOWDEN RA MCDONALD GB SCHUBERT M SHIELDS AF SLATTERY JT STORB R FISHER LD MORI M THOMAS ED HANSEN JA
Citation: Ra. Clift et al., A RANDOMIZED CONTROLLED TRIAL OF PENTOXIFYLLINE FOR THE PREVENTION OFREGIMEN-RELATED TOXICITIES IN PATIENTS UNDERGOING ALLOGENEIC MARROW TRANSPLANTATION, Blood, 82(7), 1993, pp. 2025-2030
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR 93 PATIENTS WITH MYELODYSPLASTIC SYNDROME
Authors: ANDERSON JE APPELBAUM FR FISHER LD SCHOCH G SHULMAN H ANASETTI C BENSINGER WI BRYANT E BUCKNER CD DONEY K MARTIN PJ SANDERS JE SULLIVAN KM THOMAS ED WITHERSPOON RP HANSEN JA STORB R
Citation: Je. Anderson et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR 93 PATIENTS WITH MYELODYSPLASTIC SYNDROME, Blood, 82(2), 1993, pp. 677-681
PHASE-III STUDY OF RHGM-CSF IN ALLOGENEIC MARROW TRANSPLANTATION FROMUNRELATED DONORS
Authors: ANASETTI C ANDERSON G APPELBAUM FR BUCKNER CD MARTIN PJ NEMUNAITIS J SINGER J STORB R SULLIVAN KM THOMAS ED HANSEN JA
Citation: C. Anasetti et al., PHASE-III STUDY OF RHGM-CSF IN ALLOGENEIC MARROW TRANSPLANTATION FROMUNRELATED DONORS, Blood, 82(10), 1993, pp. 10000454-10000454
Risultati: 1-25 | 26-38 |